A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells

Keyphrases

• Liposomes 100%
• Cancer Cells 100%
• Synthetic Peptides 100%
• Cisplatin 100%
• Active Targeting 100%
• Lipids 50%
• Receptor Tyrosine Kinase 50%
• Vascular Endothelial Cells 50%
• Angiogenesis 50%
• Distal End 50%
• Drug Efficacy 50%
• Endocytosis 50%
• Drug Delivery 50%
• Targeting Ligands 50%
• Anticancer Drugs 50%
• Surface Plasmon Resonance 50%
• Binding Assay 50%
• Drug Release 50%
• Metronomic Chemotherapy 50%
• MPEG 50%
• Phage Display Library 50%
• Novel Peptide 50%
• Liposome Membrane 50%
• Maleimide 50%
• DSPE-PEG2000 50%
• Cytoxicity 50%
• Tie-2 Receptor 50%
• Peptide Ligand 50%
• PEG-liposome 50%
• Liposome System 50%
• Lipid-based Formulation 50%
• Library Screening 50%
• Coated Liposomes 50%
• Antiangiogenesis Effects 50%
• Active Targeting Liposome 50%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Cisplatin 100%
• Anticancer 50%
• Lipid 50%
• Receptor Tyrosine Kinase 50%
• Angiogenesis 50%
• Endocytosis 50%
• Phage Display 50%
• Antiangiogenic Activity 50%
• Surface Plasmon Resonance 50%
• Angiopoietin Receptor 50%
• Liposome Membrane 50%
• Drug Efficacy 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Liposome 100%
• Cisplatin 100%
• Synthetic Peptide 100%
• Malignant Neoplasm 40%
• Chemotherapy 20%
• Anticarcinogen 20%
• Protein Tyrosine Kinase 20%
• Drug Release 20%
• Bacteriophage 20%
• Polyethylene Glycol 20%
• Surface Plasmon Resonance 20%
• Maleimide 20%
• Liposome Targeting 20%
• Angiopoietin Receptor 20%